Evaluation of the epidemiological profile and the mortality rate of the patients with primary cutaneous melanoma in Florianopolis - SC, Brazil;Avaliação do perfil epidemiológico e da mortalidade dos pacientes com diagnóstico de melanoma cutâneo primário no município de Florianópolis - SC, Brasil

Anais Brasileiros de Dermatologia

Volumn 84, Issue 4, 2009, Pages 335-342

  Battisti, Rúbia ^a   Nunes, Daniel Holthausen ^a,b   Weber, Ariana Lebsa ^c   Schweitzer, Louise Cardoso ^a   Sgrott, Isadora ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^c Nereu Ramos Hospital   (Brazil)

Author keywords

Melanoma; Mortality rate; Survival analysis

Indexed keywords

ADULT; ARTICLE; BRAZIL; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; YOUNG ADULT;

EID: 70350437976     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962009000400003     Document Type: Article

References (27)

1. INCA - Instituto Nacional do Câncer. [homepage] Cancer de pele melanoma. [Acesso em Set 2007]. Disponível em: http://www.inca.gov.br.
2. Lebsa-Weber A, Nunes DH, Souza Filho JJ, Carvalho- Pinto CJ. Avaliação de 496 laudos anátomo-patológicos de melanoma diagnosticados no município de Florianópolis, Santa Catarina, Brasil. An Bras Dermatol. 2007;82:227-232
3. Fernandes NC, Calmon R, Maceira JP, Cuzzi T, Silva CSC. Melanoma cutâneo: estudo prospectivo de 65 casos. An Bras Dermatol. 2005;80:25-34.
4. Borges SZ, Bakos L, Cartell A, Wagner M, Agostini A, Lersch E. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil. Int J Dermatol. 2007; 46:679-686
5. Carvalho CA, Giugliani R, Ashton-Prolla P, Cunha ME, Bakos L. Melanoma hereditário: prevalência de fatores de risco em um grupo de pacientes no Sul do Brasil. An Bras Dermatol. 2004;79:53-60.
6. Bakos L, Wagner M, Bakos RM, Leite CS, Sperhacke CL, Dzekaniak KS, et al. Sunburn, sunscreens and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol. 2002;41:557-562
7. Dennis LK. Increasing risk of melanoma with increasing age. JAMA. 1999;282:1037-1038
8. Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55:741-760
9. Gon AS, Minelli L, Guembarovski AL. Melanoma cutâneo primário em Londrina. An Bras Dermatol. 2001;76:413-426
10. Criado PR, Vasconcellos C, Sittart JAS, Valente NYS, Moura BP, Barbosa GL, et al. Melanoma maligno cutâneo primário: estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo. Rev Assoc Med Bras. 1999;45:157-162
11. Clark LN, Shin DB, Troxel AB, Khan S, Sober AJ, Ming ME. Association between the anatomic distribution of melanoma and sex. J Am Acad Dermatol. 2007;56:768-773
12. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664-1678
13. Pinheiro AMC, Cabral ALSV, Friedman H, Rodrigues HA. Melanoma cutâneo: características clínicas, epidemiológicas e histopatológicas no Hospital Universitário de Brasília entre janeiro de 1994 e abril de 1999. An Bras Dermatol. 2003;78:179-186
14. Lapa MS, Guedes KF, Schalch FO, Landman G. Melanomas malignos cutâneos tratados no Hospital de Câncer de São Paulo. Estudo retrospectivo para avaliação, fatores prognósticos e sobrevida. An Bras Dermatol. 2002;77:313-320
15. Sortino-Rachou AM, Curado MP, Latorre MRDO. Melanoma cutâneo: estudo de base populacional em Goiânia, Brasil, de 1988 a 2000. An Bras Dermatol. 2006;81:449-455
16. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902-908
17. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634
18. Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst. 2000;92:811-818
19. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 1999;40:35-42.
20. de Vries E, Schouten LJ, Visser O, Eggermont AM, Coebergh JW, Working Group of Regional Cancer Registries. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer. 2003;39:1439-1446
21. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, Larsson O, Johansson H, Ringborg U. Trends in mortality from malignant melanoma in Sweden, 1970-1996. Cancer. 2000;89:348-355
22. Ferreira CMM, Macieira JMP, Coelho JMCO. Análise imunohistopatológica, clínica e evolutiva dos melanomas. An Bras Dermatol. 1997,72:117-126
23. Kufe DW, Ollock RE, Weichselbaum RR, Bast RC, Holland JF, Frei E, et al. Cancer medicine. 7th ed. Ontario, Canada: BC Becker; 2006.
24. Garbe C, Orfanos CE. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res. 1992;Suppl 2:285-294
25. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648
26. Sim FH, Nelson TE, Pritchard DJ. Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc. 1997;72:575-579
27. Sociedade Brasileira de Dermatologia. Análise de dados das campanhas de prevenĉão de câncer de pele promovidas pela Sociedade Brasileira de Dermatologia de 1999 a 2005. An Bras Dermatol. 2006;81:533-539